Stocktoria
SBC Medical Group Holdings Inc SBC
Nasdaq · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2022-09-26
SBC Medical Group Holdings Inc financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $173.6M | $205.4M | $193.5M |
| Gross profit | $127.3M | $156.1M | $137.3M |
| SG&A expense | $59.8M | $57.7M | $66.2M |
| Operating income | $67.5M | $70.3M | $70.7M |
| Interest expense | $148,238 | $28,300 | $45,292 |
| Income tax | $31.0M | $26.8M | $35.0M |
| Net income | $51.0M | $46.6M | $39.4M |
| EPS (diluted) | $0.50 | $0.48 | $0.42 |
| Operating cash flow | $24.7M | $20.6M | $50.7M |
| Free cash flow | $23.3M | $18.0M | $42.1M |
| Cash & equivalents | $163.8M | $125.0M | $103.0M |
| Inventory | $2.8M | $1.5M | $3.1M |
| Total assets | $380.4M | $266.1M | $258.8M |
| Total liabilities | $117.1M | $71.1M | $115.0M |
| Shareholders' equity | $263.3M | $195.1M | $143.8M |
Growth · year-over-year · Revenue CAGR -5.3%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | -15.5% | +6.1% | — |
| Net income growth | +9.4% | +18.4% | — |
| EPS growth | +4.2% | +14.3% | — |
| Free cash flow growth | +29.1% | -57.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.